SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 26, 2001
Thermo Electron Corporation
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 001-8002 04-2209186
--------------------------------------- ----------------------------------- -------------------------------------
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
81 Wyman Street, P.O. Box 9046
Waltham, Massachusetts 02454-9046
------------------------------------------------------------- ------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (781) 622-1000
Not Applicable
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) EXHIBITS.
EXHIBIT NO. DESCRIPTION
----------- -----------
23 Consent of Independent Public Accountants
99.1 Definitive information statement of Viasys
Healthcare Inc. dated October 26, 2001
99.2 Forms of letters to stockholders of Thermo
Electron Corporation and Viasys Healthcare Inc.
ITEM 9. REGULATION FD DISCLOSURE.
On October 26, 2001, the U.S. Securities and Exchange Commission declared
effective the information statement on Form 10 relating to the previously
announced distribution by Thermo Electron Corporation (the "Company") to the
holders of record of the Company's common stock on November 7, 2001 of all of
the shares of Viasys Healthcare Inc. ("Viasys") on November 15, 2001 (the
"Spin-off").
The Company has filed herewith (1) the definitive information statement
providing details of the Spin-off and information about Viasys and (2) forms of
letters to stockholders of the Company and Viasys regarding the same. The
Company expects that its distribution agent, American Stock Transfer & Trust
Company, will distribute on November 15, 2001 to the holders of record of the
Company's common stock on November 7, 2001 the definitive information statement,
the letters to stockholders, the Quarterly Report on Form 10-Q of Viasys for the
quarter ended September 29, 2001 and certificates representing the shares of
Viasys common stock to be distributed in the Spin-off.
The definitive information statement of Viasys is filed as Exhibit 99.1 to
this Current Report on Form 8-K and is incorporated herein by this reference.
The forms of letters to stockholders of the Company and Viasys are filed as
Exhibit 99.2 to this Current Report on Form 8-K and are incorporated herein by
this reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: November 2, 2001 THERMO ELECTRON CORPORATION
By: /s/ Theo Melas-Kyriazi
----------------------------------------
Name: Theo Melas-Kyriazi
Title: Vice President and Chief
Financial Officer
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
----------- -----------
23 Consent of Independent Public Accounts
99.1 Definitive information statement of Viasys Healthcare Inc.
dated October 26, 2001
99.2 Forms of letters to stockholders of Thermo Electron
Corporation and Viasys Healthcare Inc.